The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: Possible therapeutic implications

In Vivo

Volumn 20, Issue 6 B, 2006, Pages 837-844

  Halapas, Antonis ^a   Diamanti Kandarakis, Evanthia ^b   Kremastinos, Demetrios ^a   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cardiac hypertrophy; Heart failure; Parathyroid hormone related protein; Review; Type 1 parathyroid hormone receptor

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN II; BRADYKININ; CALCIUM; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; NORADRENALIN; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHOLIPASE C; PROTEIN KINASE C; SEROTONIN; THROMBIN; TRANSFORMING GROWTH FACTOR BETA1;

CELL FUNCTION; CELL PROLIFERATION; DISEASE ASSOCIATION; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; MEDICAL LITERATURE; NONHUMAN; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VASOCONSTRICTION;

EID: 33846053714     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Mosterd A, Hoes AW, De Bruyne MC, Deckers JW, Linker DT, Hofman A and Grobbee DE: Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam study. Eur Heart J 20: 447-455, 1999.
2. Braunwald E and Bristw MR: Congestive heart failure: fifty years of progress. Circulation 102: 14-23, 2000.
3. Murray CJ and Lopez AD: Global mortality, disability and the contribution of risk factors: global burden of disease study. Lancet 349: 1436-1442, 1997.
4. Maron BJ: Hypertrophic cardiomyopathy. Lancet 350: 127-133, 1997.
5. Maan DL: Mechanisms and models in heart failure: a combinational approach. Circulation 100: 999-1008, 1999.
6. Zile MR and Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis and measurements of diastolic function. Circulation 105: 1387-1393, 2002.
7. Anversa P, Ricci R and Olivetti G: Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J Am Coll Cardiol 7: 1140-1149, 1986.
8. Anversa P, Beghi C, Kikkawa Y and Olivetti G: Myocardial infraction in rats. Infract size, myocyte hypertrophy, and capillary growth. Circ Res 58: 26-37, 1986.
9. Anversa P and Kajstura J: Ventricular myoeytes are not terminally differentiated in the adult mammalian heart. Circ Res 83: 1-14, 1998.
10. Beltrami AP, Urbenek K, Kajstura J, Yan SM, Finato N, Busssani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA and Anversa P: Evidence that human cardiac myocytes divide after myocardial infraction. N Engl J Med 344: 1750-1757, 2001.
11. Kajstura J, Leri A, Finato, Di Loreto C, Beltrami CA and Anversa P: Myocyte proliferation in end stage cardiac failure in humans. Proc Natl Acad Sci USA 95: 8801-8805, 1998.
12. Nadal-Ginard B, Kajstura J, Leri A and Anversa P: Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92: 139-150, 2003.
13. Zelis R, Mason DT and Braunwald E: Partition of blood flow to the cutaneous and muscular beds of the forearm at rest and during leg exercise in normal subjects and in patients with heart failure. Circ Res 24: 799, 1969.
14. Calderone A, Takahashi N, Izzo NJ, Thaik CM and Colucci WS: Pressure and volume induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 92: 2385-2390, 1995.
15. Matsui T, Agoshi T and Rosenzweig A: Akt and PI 3-Kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2: 220-223, 2003.
16. Olson EN and Williams RS: Calcineurin signaling and muscle remodeling. Cell 101: 689-692, 2000.
17. Yokoyama T, Nakano M, Bednarczyk JL, Mc Intyre BW, Entman M and Mann DL: Tumor necrosis factor alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95: 1247-1252, 1997.
18. Krum H: Tumor necrosis factor alpha blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACII): unsuccessful to be specific. J Card Fail 8: 365-368, 2002.
19. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H and Chen EY: A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression. Science 237: 893-896, 1987.
20. Martin TJ, Lato MHC, Katsogiannis V and Gillespie MT: Parathyroid hormone-related protein. In: Skeletal Growth Factors, Ernesto Canalis (ed.). Lippincott Williams & Wilkins Company, 2000.
21. Ikeda K, Weir EC, Mangin M, Dannies PS, Kinder B, Deftos LJ, Brown EM and Broadus AE: Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol Endocrinol 2: 1230-1236, 1988.
22. Weir EC, Brines ML, Ikeda K, Burtis WJ, Broadus AE and Robbins RJ: Parathyroid hormone-related peptide gene is expressed in the mammalian central nervous system. Proc Natl Acad Sci USA 87: 108-112, 1990.
23. Orloff JJ, Reddy D, De Papp AE, Yang KH, Soifer NE and Stewart AF: Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev 15: 40-60, 1994.
24. Mundy GR and Guise TA: Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and osteolytic bone disease. Endocr-Relat Cancer 5: 15-26, 1998.
25. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM and Mulligan RC: Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8: 277-289, 1994.
26. Kronenberg HM, Lanske B, Kovacs CS, Chung UI, Lee K, Segre GV, Schipani E and Juppner H: Functional analysis of the PTH/PTHrP network of ligands and receptors. Recent Prog Horm Res 53: 283-301, 1998.
27. Burtis WJ: Parathyroid hormone-related protein: structure, function, and measurement. Clin Chem 38: 2171-2183, 1992.
28. Clemens TL, Cormier S, Eichinger A, Endlich K, Fiaschi-Taesch N, Fiseher E, Friedman PA, Karaplis AC, Massfelder T, Rossert J, Schluter KD, Silve C, Stewart AF, Takane K and Helwig JJ: Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Physiol 134: 1113-1136, 2001.
29. Mannstadt M, Jüppner H and Gardella TJ: Receptors for PTH and PTHrP: their biological importante and functional properties. Am J Physiol-Renal 277: F665-F675, 1999.
30. Schluter KD: PTH and PTHrP: similar structures but different functions. News Physiol Sci 14: 243-248, 1999.
31. Bryden AAG, Islam S, Freemont AJ, Shanks JH, George NJR and Clarke NW: Parathyroid hormone-related peptide: expression in prostate cancer bone metastases. Prostate Cancer P D 5: 59-62, 2002.
32. Goomer RS, Johnson KA, Burton DW, Anniel D, Maris TM, Curjal A, Deftos LS and Terkelaub R: The tetrabasic KKKK (147-150) motif determines intracrine regulation effect of PTHrP (1-113) on chondrocyte PPi metabolism and matrix synthesis. Endocrinology 141: 4613-4622, 2000.
33. Usdin TB, Gruber C and Bonner TI: Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270: 15455-15458, 1995.
34. Usdin TB: The PTH2 receptor and TIP39: a new peptide receptor system. Trends Pharmacol Sci 21: 128-130, 2000.
35. Rubin DA and Jüppner H: Zebrafish express the common parathyroid hormone/parathyroid hormone-related peptide receptor (PTHIR) and a novel receptor (PTH3R) that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide. J Biol Chem 274: 28185-28190, 1999.
36. Castro M, Dicker F, Vilardaga JP, Krasel C, Bernhardt M and Lohse MJ: Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and β-arrestins. Endocrinology 143: 3854-3865, 2002.
37. Gardella TJ and Jüppner H: Molecular properties of the PTH/PTHrP receptor. Trends Endocrin Met 12: 210-217, 2001.
38. Knupnick JG and Benovic JL: The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Oharmacol Toxicol 38: 289-319, 1998.
39. Henderson JE, Amizuka N, Warshawsky H, Biasotto D, Lanske BM, Goltzman D and Karaplis AC: Nucleoral localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol 115: 4064-4075, 1995.
40. Veronica A, Sepulveda T and Falzon M: Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/ paracrine and intracrine pathways. Regul Peptides 105: 109-120, 2002.
41. Veronica A, Sepulveda T, Shen X and Falzon M: Intracrine PTHrP protects against serum-starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology 143: 596-606, 2002.
42. Deftos LJ: Prostate Carcinoma (Production of bioactive factors). Cancer supplement (Skeletal Complications of malignancy) 88: 3002-3008, 2000.
43. Ogata E: Parathyroid hormone-related protein as a potential target of therapy for Cancer-Associated Morbidity. Cancer supplement (Skeletal Complications of malignancy) 88: 2909-2911, 2000.
44. Lam MHC, Briggs LJ, Hu W, Martin TJ, Gillespie MT and Jans DA: Importin β recognizes parathyroid hormone-related protein (PTHrP) with high affinity and mediates its nuclear import in the absence of importin α. J Biol Chem 274: 7391-7398, 1999.
45. Watson PH, Fraher LJ, Hendy GN, Chung UI, Kisiel M, Natale BW and Hodsman AB: Nuclear localization of the type I PTH/PTHrP receptor in rat tissues. J Bone Miner Res 15: 1033-1044, 2000.
46. Guise TA: Parathyroid hormone-related protein anal bone metastases. Cancer supplement (Skeletal Complications of malignancy) 80: 1572-1580, 1997.
47. Li X and Drucker DJ: Parathyroid hormone-related peptide is a down-stream target for ras and src activation. J Biol Chem 269: 6263-6266, 1994.
48. Amling M, Neff L, Tanaka S, Inoue D, Kuida K, Weir E, Philbrick WM, Broadus AE and Baron R: Bel-2 lies down-stream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol 136: 205-213, 1997.
49. Dittmer J, Gitlin SD, Reid RL and Brady JN: Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotrophic virus type 1 Tax1: Evidente for the involvement of transcription factor ets 1. J Virol 67: 6087-6095, 1993.
50. Inoue D, Matsumoto T, Ogata E and Ikeda K: 22-Oxacalcitriol, a non-calcemic analogue of calcitriol, suppresses both cell proliferation and parathyroid hormone-related peptide gene expression in human T cell lymphotrophic virus type 1-infected T cells. J Biol Chem 268: 16730-16736, 1993.
51. Bui TD, Shallal A, Malik AN, Al-Mahdawi S, Moscoso G, Bailey ME, Burton PB and Moniz C: Parathyroid hormone-related peptide gene expression in human fetal and adult heart. Cardiovasc Res 27: 1204-1208, 1993.
52. Deftos LJ, Burton DW and Brand DW: Parathyroid hormone-like protein is a secretory product of atrial myocytes. J Clin Invest 92: 727-735, 1993.
53. Halapas A, Tenta R, Pantos C, Cokkinos DV and Koutsilieris M: Parathyroid hormone-like peptide and cardiovascular system. In Vivo 17: 425-432, 2003.
54. Schluter KD, Weber M and Piper HM: Effects of PTHrP (107-111) and PTHrP (7-34) on adult cardiomyocytes. J. Mol Cell Cardiol 29: 3057-3065, 1999.
55. Smogorzewski M, Zayed M, Zhang YB, Roe J and Massry SG: Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol 269: J1998-H2006, 1993.
56. Schluter KD, Weber M and Piper HM: Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C dependent phosphodiestarase activity. Biochem J 310: 439-444, 1995.
57. Qian J, Colbert MC, Witte D, Kuan CY, Gruenstein E, Osinka H, Lanske B, Kronenberg HM and Clemens TL: Midgestational lethality in mice lacking the parathyroid hormone (PTH)/PTH-related peptide receptor is associated with abrupt cardiomyocytes death. Endocrinology 144: 1053-1061, 2003.
58. Ogino K, Ogura K, Kinugasa Y, Furuse Y, Uchida K, Shimoyama M, Kinugawa T, Osaki S, Kato M, Tomikura Y, Igawa O, Hisatome I, Bilezikian IJ and Shigemasa S: Parathyroid hormone related protein is produced in the myocardium and increased in patients with congestive heart failure. J Clin Endocrin Metab 87: 4722-4727, 2002.
59. Giannakoulas G, Karvounis H, Koliakos G, Damvopoulou T, Karamitsos T, Papadopoulos C, Dalamanga E, Hatzitolios A, Parcharidis G and Louridas G: Parathyroid hormone-related protein is reduced in severe chronic heart failure. Peptides 27: 1894-1897, 2006.
60. Halapas A, Lembessis P, Sourla A, Pantos C, Cokkinos DV and Koutsilieris M: PTH-related protein and type 1 PTH hormone receptor mRNA expression in ventricular myocardial hypertrophy. Therapy 2: 415-423, 2005.
61. Dominiczak AF, Lyall F, Morton JJ, Dagrie HJ, Boyle IT, Tune TT, Murray G and Semple PF: Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci 78: 127-132, 1990.
62. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F and Borretta G: Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathry-roidectomy. Clin Endocrinol 50: 321-328, 1999.
63. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J and Nierderle B: Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow up. J Clin Endocrinol Metab 82: 106-112, 1997.
64. Hongo T, Kupfer J, Enomoto H, Sharifi B, Giannella-Neto D, Forrest JS, Singer FR, Goltzman D, Hendy GN, Pirola C and Clemens TL: Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanied serum-induced proliferation. J Clin Invest 88: 1841-1847, 1991.
65. Pirola CJ, Wang HM, Stragacich MI, Kamyar A, Cercek B, Forrester JS, Clemens TL and Fagin JA: Mechanical stimuli induced vascular parathyroid hormone-related protein gene expression in vivo and in vitro. Endocrinology 134: 2230-2236, 1994.
66. Pirola CJ, Wang HM, Kamyar A, Wu S, Enomoto H, Sharifi B, Forrester JS, Clemens TL and Fagin JA: Angiotensin-II regulates parathyroid hormone-related protein expression in cultured rat aortic smooth muscle cells through transcriptional and posttranscriptional mechanism. J Biol Chem 268: 1987-1994, 1993.
67. Ozeki S, Ohtsuru A, Seto S, Takeshita T, Yano H, Nakayama T, Ito M, Yokota T, Nobuyoshi M, Segre GV, Yamashita S and Yano K: Evidente that implicate the parathyroid hormone-related peptide in vascular stenosis: increased gene expression in the intima of injured carotid arteries and human restenotic coronary lesions. Arterioscl Thromb Vaso Biol 16: 565-575, 1996.
68. Degenhart H, Jansen J, Schulz R, Sedding D, Braun Dullaeus R and Schluter KD: Mechanosensitive release of parathyroid hormone-related peptide from coronary endothelial cells. Am J Physiol Heart Circ Physiol 283: H1489-H1496, 2002.
69. Daifotis AG, Weir EC, Dreyer BE and Broadus AE: Stretch-induced parathyroid hormone-related peptide gene expression in the uterus. J Biol Chem 267: 23455-23458, 1992.
70. Eto M, Akishita M, Ishikawa M, Kozaki K, Yoshizumi M, Hashimoto M, Ako J, Sugimoto N, Nagano K, Sudoth N, Toba K and Ouchi Y: Cytokine-induced expression of Parathyroid hormone-related peptide in cultured human vascular endothelial cells. Bioch Bioph Res Comm 249: 339-343, 1998.